{"skill":{"slug":"crispr-therapeutics","displayName":"Crispr Therapeutics","summary":"CRISPR Therapeutics develops CRISPR-Cas9 gene editing therapies, including FDA-approved Casgevy for sickle cell disease, partnering with Vertex Pharmaceuticals.","tags":{"latest":"1.0.0"},"stats":{"comments":0,"downloads":104,"installsAllTime":0,"installsCurrent":0,"stars":0,"versions":1},"createdAt":1778264679753,"updatedAt":1778492880688},"latestVersion":{"version":"1.0.0","createdAt":1778264679753,"changelog":"- First public release of the CRISPR Therapeutics skill\n- Provides company background, major milestones, and business overview\n- Highlights CRISPR-Cas9's clinical and regulatory achievements, including the 2023 FDA approval of Casgevy\n- Covers competitive advantages, financial metrics, and collaboration details\n- Useful for understanding the commercialization and market impact of CRISPR gene editing therapies","license":"MIT-0"},"metadata":null,"owner":{"handle":"hanxueyuan","userId":"s17eht14r6y7ztwaw37n96ka7583eghn","displayName":"hanxueyuan","image":"https://avatars.githubusercontent.com/u/16717383?v=4"},"moderation":null}